fbpx
Medical Innovation Exchange

After late-study endpoint switch, Aldeyra hails success of phase 3 dry eye disease trial

https://www.fiercebiotech.com/biotech/after-late-study-endpoint-switch-aldeyra-hails-success-phase-3-dry-eye-disease-trial

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.